Kotlyar J, Granstein R
Brain Behav Immun Health. 2025; 44:100958.
PMID: 40008232
PMC: 11851231.
DOI: 10.1016/j.bbih.2025.100958.
Teo L, Juantuah-Kusi N, Subramanian G, Sampath P
Noncoding RNA. 2025; 11(1).
PMID: 39997616
PMC: 11858470.
DOI: 10.3390/ncrna11010016.
Cagnotto G, Bruschettini M, Strozyk A, Scire C, Compagno M
Cochrane Database Syst Rev. 2025; 2:CD013614.
PMID: 39945386
PMC: 11822884.
DOI: 10.1002/14651858.CD013614.pub2.
Bharatha M, Nandana M, Vishwanath B, Rajaiah R
Arch Dermatol Res. 2025; 317(1):357.
PMID: 39918641
DOI: 10.1007/s00403-025-03878-9.
Thakur R, Kumar A, Aggarwal K, Sood N, Khare S, Patel P
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39847054
DOI: 10.1007/s00210-025-03804-w.
S1PR3-driven positive feedback loop sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis.
Lian P, Li L, Lu R, Zhang B, Wazir J, Gu C
Cell Death Dis. 2025; 16(1):31.
PMID: 39833165
PMC: 11746942.
DOI: 10.1038/s41419-025-07358-w.
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.
Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N
Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748
PMC: 11734941.
DOI: 10.1038/s41392-024-02080-z.
A Hybrid Model for Psoriasis Subtype Classification: Integrating Multi Transfer Learning and Hard Voting Ensemble Models.
Avci I, Zirekgur M, Karakaya B, Demir B
Diagnostics (Basel). 2025; 15(1.
PMID: 39795583
PMC: 11719686.
DOI: 10.3390/diagnostics15010055.
Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing.
Rodriguez-Fernandez K, Zarzoso-Foj J, Saez-Bello M, Mateu-Puchades A, Martorell-Calatayud A, Merino-Sanjuan M
Pharmaceutics. 2025; 16(12.
PMID: 39771555
PMC: 11678170.
DOI: 10.3390/pharmaceutics16121576.
The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression.
Mustata M, Ionescu M, Radu L, Neagoe C, Ahritculesei R, Cimpeanu R
Diagnostics (Basel). 2025; 14(24.
PMID: 39767248
PMC: 11675552.
DOI: 10.3390/diagnostics14242887.
The Intersection of Psoriasis and Neoplasia: Risk Factors, Therapeutic Approaches, and Management Strategies.
Mateescu L, Savu A, Mutu C, Vaida C, Serban E, Bucur S
Cancers (Basel). 2025; 16(24.
PMID: 39766123
PMC: 11674284.
DOI: 10.3390/cancers16244224.
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?.
Cui X, Liu W, Jiang H, Zhao Q, Hu Y, Tang X
J Transl Autoimmun. 2025; 10:100263.
PMID: 39759268
PMC: 11697604.
DOI: 10.1016/j.jtauto.2024.100263.
Parental Consanguinity and Family History in Relation to Psoriasis and the Role of Sex: A Case-Control Study.
AlKhas A, Ziyab A
Hum Hered. 2024; 90(1):1-9.
PMID: 39740656
PMC: 11844690.
DOI: 10.1159/000543351.
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L
J Pers Med. 2024; 14(12).
PMID: 39728081
PMC: 11680027.
DOI: 10.3390/jpm14121169.
Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio associated with psoriasis: a cross-sectional study.
Liu X, Li K, Huang T, Tang H
Front Med (Lausanne). 2024; 11:1514275.
PMID: 39712184
PMC: 11659000.
DOI: 10.3389/fmed.2024.1514275.
Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases.
Seremet T, Di Domizio J, Girardin A, Yatim A, Jenelten R, Messina F
Nat Commun. 2024; 15(1):10688.
PMID: 39695162
PMC: 11655867.
DOI: 10.1038/s41467-024-54559-6.
Study of the Gut Microbiome in Patients with Psoriatic Arthritis.
Amorim G, Ricardo Werner Castro G, Carneiro S
Eur J Rheumatol. 2024; 11(2):46-52.
PMID: 39576066
PMC: 11448769.
DOI: 10.5152/eurjrheum.2024.23080.
Impact of tobacco smoking and alcohol consumption on the treatment efficacy among psoriasis patients: A study protocol.
Shen F, Ding Y, Wang R
Tob Induc Dis. 2024; 22.
PMID: 39569104
PMC: 11577767.
DOI: 10.18332/tid/195380.
Profiling CARD14 gene expression in Indian Psoriasis patients.
Singh S, Pradhan D, Puri P, Sharma S, Jain A
Sci Rep. 2024; 14(1):28798.
PMID: 39567556
PMC: 11579362.
DOI: 10.1038/s41598-024-78267-9.
Alpha-Pinene-encapsulated lipid nanoparticles diminished inflammatory responses in THP-1 cells and imiquimod-induced psoriasis-like skin injury and splenomegaly in mice.
Li T, Liang W, Zhao Y, Chen W, Zhu H, Duan Y
Front Immunol. 2024; 15:1390589.
PMID: 39534602
PMC: 11554515.
DOI: 10.3389/fimmu.2024.1390589.
